Wachovia Upgrades Genesis Healthcare

Analyst Joel Ray says he is encouraged by the success in the company's 3-year, operational excellence initiative

Wachovia upgraded Genesis Healthcare (GHCI ) to outperform from market perform, and increased its price target from $30 to $36 to $40.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.